Tivicay, Triumeq And Juluca (dolutegravir Containing Medicines) – Possible Risk Of Neural Tube Defects

Recall Summary Three HIV medications containing dolutegravir (TIVICAY, TRIUMEQ, and JULUCA) are being recalled in Canada due to a possible risk of neural tube defects in babies if taken by pregnant women. The medications have been distributed across Canada. Anyone currently taking these drugs who is pregnant or planning to become pregnant should be aware of this safety concern.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2018-06-07

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/40d3a569-97a8-4c0d-b598-3c8fedb46d30